ARAY vs CME · rev $401.9M vs P/E 22, rev $3.59B
Accuray Incorporated (ARAY) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
Accuray Incorporated (ARAY) is a medical devices company listed on US.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported ARAY revenue for 2026-06-30 was $401.9M. Net income was -$49.2M. Revenue was down 12.3% from 2025-06-30 to 2026-06-30. ARAY currently screens at market cap $140.1M.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
ARAY currently screens at market cap $140.1M. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the ARAY and CME stock pages for the full models.
Not investment advice.